Pill-Based leukemia treatment challenges standard IV chemo
NCT ID NCT04817241
Summary
This study is testing whether a combination of pills (ASTX727 and venetoclax) is as safe and effective as standard intravenous chemotherapy for younger adults with a high-risk type of acute myeloid leukemia (AML). The goal is to control the cancer and improve survival. The trial first finds a safe dose, then compares the pill combination to the standard treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Montefiore Medical Center - Moses Campus
The Bronx, New York, 10467, United States
-
Montefiore Medical Center-Einstein Campus
The Bronx, New York, 10461, United States
-
Roswell Park Cancer Institute
Buffalo, New York, 14263, United States
-
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, 35233, United States
-
University of Virginia Cancer Center
Charlottesville, Virginia, 22908, United States
-
Vanderbilt University/Ingram Cancer Center
Nashville, Tennessee, 37232, United States
-
Yale University
New Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.